In millions, except per share items | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Cash flows from operating activities: | | | | | | | | |
Net loss | -1.2 | -0.7 | -1.4 | -1.4 | -0.5 | -1.1 | -0.6 | -2.9 |
Adjustments to reconcile net loss to net cash (used in) from operating activities: | | | | | | | | |
Depreciation and amortization | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
Interest from amortization of debt costs | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
(Gain) loss on disposal of property and equipment | -0.1 | | | | 0.0 | | | |
Stock-based compensation on stock options, RSUs & RSAs, net | 0.3 | 0.8 | | | 0.2 | 0.3 | | |
Provision for doubtful accounts receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 |
Change in operating lease assets and liabilities | 0.0 | -0.1 | | | -0.1 | -0.1 | | |
Inventory write-offs to allowance | 0.1 | 0.0 | | 0.3 | 0.1 | 0.0 | 0.1 | 0.0 |
Deferred tax benefit | 0.0 | 0.0 | 0.0 | | | | | |
Changes in operating assets and liabilities: | | | | | | | | |
Trade accounts receivable | 0.0 | -0.2 | 0.6 | -0.3 | 0.0 | 0.8 | -1.1 | 1.7 |
Other receivables | 0.1 | -0.1 | | | 0.2 | -0.1 | | 0.0 |
Inventories | -1.4 | 0.1 | 0.0 | 0.4 | -0.4 | 1.3 | -0.1 | 0.2 |
Prepaid expenses and other assets | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Accounts payable and accrued liabilities | 1.1 | -0.6 | -0.6 | 0.4 | 0.0 | -0.7 | -0.8 | 1.1 |
Net cash (used in) provided by operating activities | -0.2 | -0.3 | -0.4 | 1.1 | 0.5 | 1.5 | -1.6 | 1.7 |
|
Cash flows from investing activities: | | | | | | | | |
Purchase of property and equipment | -1.9 | -0.2 | -0.2 | -1.6 | -0.2 | -0.1 | -1.2 | -3.2 |
Proceeds from sale of equipment | 0.1 | | | | | | | |
Net cash used in investing activities | -1.8 | -0.2 | -0.2 | -0.1 | -0.2 | -0.1 | -1.2 | -0.4 |
|
Cash flows from financing activities: | | | | | | | | |
Proceeds from sale of common stock from Employee Stock Purchase Plan | 0.0 | | 0.0 | | 0.0 | | 0.0 | 0.0 |
Proceeds from issuance of common stock under public equity placement | 9.2 | | | | | | | |
Loan costs | | | | | | -0.1 | | |
Borrowings on loans payable | | | | | | | 0.3 | |
Payments on loans payable | -1.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.5 |
Repayment of finance lease obligations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 |
Net cash provided by (used in) financing activities | 8.0 | -0.3 | -0.2 | -0.2 | -0.2 | -0.3 | 0.1 | -0.5 |
Effect of exchange rate on cash and cash equivalents | 0.2 | 0.3 | -0.4 | -0.5 | 0.0 | 0.0 | 0.0 | 0.1 |
Change in cash and cash equivalents | 6.1 | -0.5 | -1.2 | 0.3 | 0.2 | 1.1 | -2.8 | 0.8 |
Cash and cash equivalents, beginning of period | -5.5 | | 5.5 | | | | 6.8 | |
Cash and cash equivalents, end of period | -3.8 | -0.5 | 4.3 | 0.3 | 0.2 | 1.1 | 4.0 | 0.8 |
|
Supplemental disclosure of cash flow information: | | | | | | | | |
Interest paid in cash | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes paid | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 |
Supplemental disclosure of non-cash investing & financing activities: | | | | | | | | |
Purchase of equipment through finance lease arrangements | | | | | | | | |